IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Bharat Immunologicals

BSE:BIBCL · ISIN INE994B01014

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Bharat Immunologicals

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Continues to remain under issuer non-cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Continues to remain under issuer Non-Cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Continues to remain under issuer Non-Cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Ratings moved to the Issuer Not Cooperating CategoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Ratings reaffirmed at [ICRA]B+ (Stable)/A4; removed from ‘Issuer Non Cooperating’ categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Moved to Non-Cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Ratings revised to [ICRA]B+ (Stable)/ [ICRA]A4; removed from issuer not cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · Bharat Immunologicals & Biologicals Corporation Limited: Ratings downgraded to [ICRA]BB-(Negative)/A4 based on best available information; Ratings continue to be in the Issuer Not Cooperating categoryICRA Limited · discovered
Agency source
ICRA Limited · ICRA revises the outlook of Bharat Immunologicals and Biologicals Corporation Limited to Negative; moves the ratings to ‘Issuer Not Cooperating’ categoryICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium